drugset / Trial / NCT05983770
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.
Timeline
- Start
- 2023-08-30
- Primary completion
- 2025-09-11
- Completion
- 2025-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | — | — |
| Subject | Tegoprubart | Monoclonal antibody | 20 mg/kg | Intravenous |